Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C

被引:2
|
作者
Li, Xiaodan [1 ]
Brunner, Cyrill [2 ]
Wu, Yufan [1 ]
Leka, Oneda [1 ]
Schneider, Gisbert [2 ]
Kammerer, Richard A. [1 ]
机构
[1] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland
[2] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, RETHINK, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Botulinum neurotoxin; Synaptic vesicle glycoprotein 2; Protein receptor; Crystal structure; Surface plasmon resonance; Mutagenesis; Biophysics; Plasticity; Protein-protein interactions; Protein-carbohydrate interactions; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; BACILLUS-THURINGIENSIS; SYNAPTOTAGMIN-I; TOXIN; BINDING; IDENTIFICATION; BLOCKADE; DOMAIN;
D O I
10.1016/j.toxicon.2019.11.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A dual-receptor interaction with a polysialoganglioside and synaptic vesicle glycoprotein 2 (SV2) is required for botulinum neurotoxin A (BoNT) toxicity. Here, we review what is currently known about the BoNT/A-SV2 interaction based on structural studies. Currently, five crystal structures of the receptor-binding domain (Hc) of BoNT subtypes A1 and A2 complexed to the large luminal domain (LD4) of SV2C have been determined. On the basis of the available structures, we will discuss the importance of protein-protein and protein-carbohydrate interactions for BoNT/A toxicity as well as the high plasticity of BoNT/A for receptor recognition by tolerating a variety of side-chain interactions at the interface. A plausible explanation how receptor-binding specificity of BoNT/A may be achieved without an extensive and conserved side chain-side chain interaction network will be provided.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [31] Interaction between botulinum neurotoxin type A and ganglioside: Ganglioside inactivates the neurotoxin and quenches its tryptophan fluorescence
    Kamata, Y
    Yoshimoto, M
    Kozaki, S
    TOXICON, 1997, 35 (08) : 1337 - 1340
  • [32] SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
    Lezzi, M
    Theander, S
    Janz, R
    Loze, C
    Wollheim, CB
    JOURNAL OF CELL SCIENCE, 2005, 118 (23) : 5647 - 5660
  • [33] Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis
    Berliocchi, L
    Fava, E
    Leist, M
    Horvat, V
    Dinsdale, D
    Read, D
    Nicotera, P
    JOURNAL OF CELL BIOLOGY, 2005, 168 (04): : 607 - 618
  • [34] Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
    Peng, Lisheng
    Tepp, William H.
    Johnson, Eric A.
    Dong, Min
    PLOS PATHOGENS, 2011, 7 (03):
  • [35] N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
    Yao, Guorui
    Zhang, Sicai
    Mahrhold, Stefan
    Lam, Kwok-ho
    Stern, Daniel
    Bagramyan, Karine
    Perry, Kay
    Kalkum, Markus
    Rummel, Andreas
    Dong, Min
    Jin, Rongsheng
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2016, 23 (07) : 656 - 662
  • [36] N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
    Guorui Yao
    Sicai Zhang
    Stefan Mahrhold
    Kwok-ho Lam
    Daniel Stern
    Karine Bagramyan
    Kay Perry
    Markus Kalkum
    Andreas Rummel
    Min Dong
    Rongsheng Jin
    Nature Structural & Molecular Biology, 2016, 23 : 656 - 662
  • [37] Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
    Dunn, Amy R.
    Stout, Kristen A.
    Ozawa, Minagi
    Lohr, Kelly M.
    Hoffman, Carlie A.
    Bernstein, Alison I.
    Li, Yingjie
    Wang, Minzheng
    Sgobio, Carmelo
    Sastry, Namratha
    Cai, Huaibin
    Caudle, W. Michael
    Miller, Gary W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (11) : E2253 - E2262
  • [38] Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
    Jin, Rongsheng
    Rummel, Andreas
    Binz, Thomas
    Brunger, Axel T.
    NATURE, 2006, 444 (7122) : 1092 - 1095
  • [39] Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE Study
    Ramsey, Timothy L.
    Liu, Qian
    Massey, Bill W.
    Brennan, Mark D.
    SCHIZOPHRENIA RESEARCH, 2013, 149 (1-3) : 21 - 25
  • [40] SV2C is required for nicotine-mediated rescue of alpha-synuclein neurotoxicity
    Clemens, Sabrina
    Olsen, Abby
    NEUROLOGY, 2021, 96 (15)